3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Completed
3
Terminated
2
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
43
Neoplasm Metastasis
5
Neoplasms
4
Ovarian Neoplasms
3
Hereditary Sensory and Autonomic Neuropathies
3
Carcinoma, Non-Small-Cell Lung
3
Endometrial Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Breast Cancer Metastatic
2
Advanced Breast Cancer
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Lymphoma, Non-Hodgkin
1
Hyperglycemia
1
HER2-positive Metastatic Breast Cancer
1
HER2-positive Breast Cancer
1
Female Breast Carcinoma
1
Exanthema
1
Carcinosarcoma
1
Carcinoma, Lobular
1
Breast Neoplasms, Male
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Adenocarcinoma Of Esophagus
1
Interventions
Fulvestrant
2
tusamitamab ravtansine
1
palbociclib
1
nirogacestat
1
exemestane
1
Tamoxifen
1
Letrozole
1
Gemcitabine
1
Docetaxel
1
Capecitabine
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Breast Cancer Metastatic
×
Fulvestrant
×
Clear all
NCT04059484
2026-02-24
AMEERA-3
Sanofi
Phase 2
Terminated
367 enrolled
30 charts
NCT03322215
2024-03-08
PASIPHAE
Karolinska University Hospital
Phase 2
Terminated
42 enrolled